In the review the data on use of genetically modified microorganisms as producers of proteins of different organisms are presented. The relative advantages and disadvantages of bacterial and yeast systems for heterologous genes expression are considered
Since the approval of recombinant insulin from Escherichia coli for its clinical use in the early 19...
Abstract Gram-negative bacteria are attractive hosts for recombinant protein production because they...
Both conventional and innovative biomedical approaches require cost-effective protein drugs with hig...
Most of the hosts used to produce the 151 recombinant pharmaceuticals so far approved for human use ...
peer reviewedHumans have been using microorganisms for our benefit for millennia, initially by harve...
Current, very fast development of genetic engineering and protein engineering (main segments of mode...
Recombinant DNA technology has created biological organisms with advanced genetic sequences and has ...
With the advent of recombinant DNA technology, expressing heterologous proteins in microorganisms ra...
Australasian Biotechnology, Volume 6 Number 4, July/August 1996,pp.230-237 Production of therapeutic...
A number of Gram-positive bacteria are important players in industry as producers of a diverse array...
Recombinant protein production emerged in the early 1980s with the development of genetic engineerin...
Yeasts have been known and used in food and alcoholic fermentations ever since the Neolithic Age. In...
Both conventional and innovative biomedical approaches require cost-effective protein drugs with hig...
Since the approval of recombinant insulin from Escherichia coli for its clinical use in the early 19...
This study has been part of the project Development of versatile bacterial expression systems for u...
Since the approval of recombinant insulin from Escherichia coli for its clinical use in the early 19...
Abstract Gram-negative bacteria are attractive hosts for recombinant protein production because they...
Both conventional and innovative biomedical approaches require cost-effective protein drugs with hig...
Most of the hosts used to produce the 151 recombinant pharmaceuticals so far approved for human use ...
peer reviewedHumans have been using microorganisms for our benefit for millennia, initially by harve...
Current, very fast development of genetic engineering and protein engineering (main segments of mode...
Recombinant DNA technology has created biological organisms with advanced genetic sequences and has ...
With the advent of recombinant DNA technology, expressing heterologous proteins in microorganisms ra...
Australasian Biotechnology, Volume 6 Number 4, July/August 1996,pp.230-237 Production of therapeutic...
A number of Gram-positive bacteria are important players in industry as producers of a diverse array...
Recombinant protein production emerged in the early 1980s with the development of genetic engineerin...
Yeasts have been known and used in food and alcoholic fermentations ever since the Neolithic Age. In...
Both conventional and innovative biomedical approaches require cost-effective protein drugs with hig...
Since the approval of recombinant insulin from Escherichia coli for its clinical use in the early 19...
This study has been part of the project Development of versatile bacterial expression systems for u...
Since the approval of recombinant insulin from Escherichia coli for its clinical use in the early 19...
Abstract Gram-negative bacteria are attractive hosts for recombinant protein production because they...
Both conventional and innovative biomedical approaches require cost-effective protein drugs with hig...
DOI
Add to ORKG